EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanomaterials Boost CAR‐T Therapy for Solid Tumors

Jun Long, Yian Wang, Xianjie Jiang, Junshang Ge, Mingfen Chen, Boshu Zheng, Rong Wang, Meifeng Wang, Meifang Xu, Qi Ke, Jie Wang iD

Advanced Healthcare Materials · 2024-08 · 13 (20)

DOI: 10.1002/adhm.202304615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 21.05.2024. Verfasst von Jun Long und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Geim Graphene Center, Tsinghua-Berkeley Shenzhen Institute & Tsinghua Shenzhen International Graduate School, Tsinghua University, 1001 Xuey…. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms, Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 176 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Fujian Provincial Project of Education and Science for Young and Middle-aged Teachers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell engineering, particularly via chimeric antigen receptor (CAR) modifications for enhancing tumor specificity, has shown efficacy in treating hematologic malignancies. The extension of CAR‐T cell therapy to solid tumors, however, is impeded by several challenges: The absence of tumor‐specific antigens, antigen heterogeneity, a complex immunosuppressive tumor microenvironment, and physical barriers to cell infiltration. Additionally, limitations in CAR‐T cell manufacturing capacity and the high costs associated with these therapies restrict their widespread application. The integration of nanomaterials into CAR‐T cell production and application offers a promising avenue to mitigate these challenges. Utilizing nanomaterials in the production of CAR‐T cells can decrease product variability and lower production expenses, positively impacting the targeting and persistence of CAR‐T cells in treatment and minimizing adverse effects. This review comprehensively evaluates the use of various nanomaterials in the production of CAR‐T cells, genetic modification, and in vivo delivery. It discusses their underlying mechanisms and potential for clinical application, with a focus on improving specificity and safety in CAR‐T cell therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanostructuresNeoplasmsImmunotherapy, AdoptiveReceptors, Chimeric AntigenHumansAnimalsT-LymphocytesTumor Microenvironment

Stichwörter der Autor:innen

chimeric antigen receptor T cellsimmunotherapynanomaterialssolid tumors

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Shenzhen Geim Graphene Center, Tsinghua-Berkeley Shenzhen Institute & Tsinghua Shenzhen International Graduate School, Tsinghua University, 1001 Xueyuan Road, Shenzhen, 518055, China.
  • The Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, School of Medicine, Hunan Normal University, The Engineering Research Center of Reproduction and Translational Medicine of Hunan Province, Cha…
  • Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China.
  • Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medicine Sciences, Central South University, Changsha, 410078, China.
  • Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Fujian Medical University, Quanzhou, 362000, China.
  • Department of Pathology and Institute of Oncology, The School of Basic Medical Sciences & Diagnostic Pathology Center, Fujian Medical University, No.1 Xuefu North Road University Town, Fuzhou, 350122, China.

ORCID-Profile: Jie Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province
  • Fujian Provincial Project of Education and Science for Young and Middle-aged Teachers
  • Startup Foundation of Fujian Medical University

Zitieren

APA

Long, J., Wang, Y., Jiang, X., Ge, J., Chen, M., Zheng, B., Wang, R., Wang, M., Xu, M., Ke, Q., & Wang, J. (2024). Nanomaterials Boost CAR‐T Therapy for Solid Tumors. Advanced Healthcare Materials, 13(20). https://doi.org/10.1002/adhm.202304615

Vancouver

Long J, Wang Y, Jiang X, Ge J, Chen M, Zheng B, et al. Nanomaterials Boost CAR‐T Therapy for Solid Tumors. Advanced Healthcare Materials. 2024;13(20). doi:10.1002/adhm.202304615

BibTeX
@article{Long2024,
  author = {Long, Jun and Wang, Yian and Jiang, Xianjie and Ge, Junshang and Chen, Mingfen and Zheng, Boshu and Wang, Rong and Wang, Meifeng and Xu, Meifang and Ke, Qi and Wang, Jie},
  title = {Nanomaterials Boost CAR‐T Therapy for Solid Tumors},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {20},
  doi = {10.1002/adhm.202304615}
}
Kostenlos starten →